In a hurdle for China’s vaccine diplomacy in Nepal, the former’s condition for signing of a non-disclosure agreement is said to have put the Nepalese government in a fix, reports Economic Times.
The non-disclosure agreement would imply a legally binding contract under which Nepal will not be making details like pricing public. Other such details in the agreement could also include trade secrets, intellectual property, product formulas, information about products under development, computer code, financial information, and contractual agreements with other companies and proprietary information.
The Nepalese government is expecting to hear back from Chinese vaccine maker Sinopharm on aspects like quantity, price and delivery schedule only after the non-disclosure agreement is signed.
This gains significance as, as per Nepal’s Public Procurement Monitoring Office, except in the situation of the Government procuring defence-related materials, details of procurement must be disclosed under the Nepalese law.
This comes as a hurdle for China to push the use of its vaccines in India’s neighbourhood.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.